Join to View Full Profile
200 1st Street SWRochester, MN 55905
Dr. Mansfield is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Aaron Mansfield, based in Rochester, MN, specializes in oncology with a subspecialty in thoracic cancer. He completed his medical training at the University of California, Irvine, followed by a residency in internal medicine and a fellowship in hematology and medical oncology at the Mayo Clinic. Dr. Mansfield is a professor at Mayo Clinic College of Medicine. His research focuses on thoracic malignancies including lung cancer, mesothelioma, and thymic cancers, with numerous high impact publications. He has been involved in multiple clinical trials, particularly on targeted therapy, and immunotherapy. Dr. Mansfield has received several awards, including the Tow Shung Tan Humanism in Medicine Award and the Hematology/Oncology Outstanding Achievement Award from Mayo Clinic.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2009 - 2013
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
- University of California, Irvine, School of MedicineClass of 2006
- Stanford UniversityB.A., Human Biology, 1997 - 2001
Certifications & Licensure
- MN State Medical License 2007 - 2025
- CA State Medical License 2010 - 2012
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Tow Shung Tan Humanism in Medicine Award Mayo Clinic, 2013
- Hematology/Oncology Outstanding Achievement Award Mayo Clinic, 2013
- Ed Creagan Melanoma Research Award Mayo Clinic, 2013
- Join now to see all
Clinical Trials
- Phase I Study of LB-100 With Docetaxel in Solid Tumors Start of enrollment: 2013 Feb 01
- Collection and Storage of Tissue and Blood Samples From Patients With Cancer Start of enrollment: 2015 May 19
- M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2019 Apr 16
- Join now to see all
Publications & Presentations
PubMed
- Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial.Jacob J Orme, Henan Zhang, Prashanth Lingamaneni, Yohan Kim, Roxane Lavoie
Nature Communications. 2025-03-13 - Evaluation of Innate Immune System, Body Habitus, and Sex on the Pharmacokinetics and Pharmacodynamics of Anetumab Ravtansine in Patients With Cancer.Li Chen, Andrew T Lucas, Aaron S Mansfield, Stephanie Lheureux, Claire O'Connor
Clinical and Translational Science. 2025-03-01 - 2 citationsTransforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.Amye J Tevaarwerk, Dhauna Karam, Clare A Gatten, Elizabeth S Harlos, Matthew J Maurer
Cancer. 2025-01-01
Journal Articles
- Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trialsMansfield AS, Symanowski JT, Peikert T, Lung Cancer, 1/1/2014
- Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysisPhan M, John S, Casanegra AI, Rathbun S, Mansfield A, Stoner JA, Tafur AJ, J Thromb Thrombolysis, 1/1/2014
Books/Book Chapters
Abstracts/Posters
- Programmed cell death 1 ligand 1 expression and association with survival in mesotheliomaMansfield AS, Peikert T, Roden A, Krco C, Harrington S, Dong H, Kwon E, Thorac Oncol, 1/1/2014
- Immune cell profile of the sln has prognostic value in stage iii melanomaGrotz TE, Mansfield AS, Jakub JW, Markovic SN, Hieken TJ, Cancer Res, 1/15/2013
- Dna methylation and expression patterns in adenocarcinomas of the lung of never-smokers with discordant methylation and expression patterns of homeobox related genesMansfield AS, Wang L, Cunningham JM, Jen J, Kolbert C, Sun ZF, Yang P, J Thorac Oncol, 1/1/2013
- Join now to see all
Lectures
- Identifying Appropriate Trials for Our Patients and Considering Compassionate Use Programs2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- LB-100: Rethinking protein phosphorylationSanta Monica, CA - 1/1/2014
- Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trialsCape Town, South Africa (2014); Perth, Australia (2014) - 1/1/2014
- Join now to see all
Press Mentions
- Mayo Clinic Opens New Doors in Cancer Treatment InnovationJanuary 28th, 2025
- Mayo Clinic Reveals New Test for MesotheliomaNovember 18th, 2024
- Mayo Clinic Develops Mesothelioma Detection MethodNovember 7th, 2024
- Join now to see all
Grant Support
- Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopyUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN2023–2026
- NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1MAYO CLINIC ROCHESTER2019–2025
Professional Memberships
- Associate
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: